nodes	percent_of_prediction	percent_of_DWPC	metapath
Gefitinib—Lapatinib—ERBB2—meningioma	0.048	0.585	CrCbGaD
Gefitinib—Afatinib—ERBB2—meningioma	0.034	0.415	CrCbGaD
Gefitinib—SBK1—medulla oblongata—meningioma	0.0124	0.0548	CbGeAlD
Gefitinib—SBK1—spinal cord—meningioma	0.0111	0.0489	CbGeAlD
Gefitinib—SBK1—cerebellum—meningioma	0.00878	0.0388	CbGeAlD
Gefitinib—SBK1—brain—meningioma	0.00713	0.0315	CbGeAlD
Gefitinib—HIPK4—brain—meningioma	0.00705	0.0311	CbGeAlD
Gefitinib—CSNK1E—medulla oblongata—meningioma	0.00686	0.0303	CbGeAlD
Gefitinib—IRAK4—medulla oblongata—meningioma	0.00675	0.0298	CbGeAlD
Gefitinib—MAP2K5—brainstem—meningioma	0.00655	0.0289	CbGeAlD
Gefitinib—MKNK2—medulla oblongata—meningioma	0.00629	0.0278	CbGeAlD
Gefitinib—MKNK1—medulla oblongata—meningioma	0.00621	0.0274	CbGeAlD
Gefitinib—CHEK2—brain—meningioma	0.00621	0.0274	CbGeAlD
Gefitinib—CSNK1E—spinal cord—meningioma	0.00611	0.027	CbGeAlD
Gefitinib—IRAK4—spinal cord—meningioma	0.00602	0.0266	CbGeAlD
Gefitinib—ERBB3—spinal cord—meningioma	0.0059	0.0261	CbGeAlD
Gefitinib—MKNK2—spinal cord—meningioma	0.00561	0.0248	CbGeAlD
Gefitinib—EPHA6—brain—meningioma	0.00557	0.0246	CbGeAlD
Gefitinib—MKNK1—spinal cord—meningioma	0.00554	0.0245	CbGeAlD
Gefitinib—MAP3K19—brain—meningioma	0.00506	0.0224	CbGeAlD
Gefitinib—EGFR—cerebellum—meningioma	0.00504	0.0223	CbGeAlD
Gefitinib—CSNK1E—cerebellum—meningioma	0.00485	0.0214	CbGeAlD
Gefitinib—IRAK4—cerebellum—meningioma	0.00477	0.0211	CbGeAlD
Gefitinib—ERBB3—cerebellum—meningioma	0.00468	0.0207	CbGeAlD
Gefitinib—MAP2K5—medulla oblongata—meningioma	0.00457	0.0202	CbGeAlD
Gefitinib—MKNK2—cerebellum—meningioma	0.00445	0.0197	CbGeAlD
Gefitinib—IRAK1—cerebellum—meningioma	0.00445	0.0197	CbGeAlD
Gefitinib—MKNK1—cerebellum—meningioma	0.00439	0.0194	CbGeAlD
Gefitinib—EGFR—brain—meningioma	0.00409	0.0181	CbGeAlD
Gefitinib—MAP2K5—spinal cord—meningioma	0.00407	0.018	CbGeAlD
Gefitinib—CSNK1E—brain—meningioma	0.00394	0.0174	CbGeAlD
Gefitinib—IRAK4—brain—meningioma	0.00388	0.0171	CbGeAlD
Gefitinib—ERBB3—brain—meningioma	0.0038	0.0168	CbGeAlD
Gefitinib—STK10—cerebellum—meningioma	0.00362	0.016	CbGeAlD
Gefitinib—MKNK2—brain—meningioma	0.00361	0.016	CbGeAlD
Gefitinib—IRAK1—brain—meningioma	0.00361	0.016	CbGeAlD
Gefitinib—MKNK1—brain—meningioma	0.00357	0.0158	CbGeAlD
Gefitinib—ORM1—spinal cord—meningioma	0.00331	0.0146	CbGeAlD
Gefitinib—MAP2K5—cerebellum—meningioma	0.00323	0.0143	CbGeAlD
Gefitinib—STK10—brain—meningioma	0.00294	0.013	CbGeAlD
Gefitinib—MAP2K5—brain—meningioma	0.00262	0.0116	CbGeAlD
Gefitinib—ABCG2—medulla oblongata—meningioma	0.00222	0.00982	CbGeAlD
Gefitinib—CYP2D6—brainstem—meningioma	0.00218	0.00965	CbGeAlD
Gefitinib—ABCG2—spinal cord—meningioma	0.00198	0.00875	CbGeAlD
Gefitinib—ALB—brain—meningioma	0.00187	0.00825	CbGeAlD
Gefitinib—ABCG2—cerebellum—meningioma	0.00157	0.00694	CbGeAlD
Gefitinib—ABCG2—brain—meningioma	0.00128	0.00564	CbGeAlD
Gefitinib—CYP1A1—brain—meningioma	0.00121	0.00535	CbGeAlD
Gefitinib—ABCB1—medulla oblongata—meningioma	0.0011	0.00484	CbGeAlD
Gefitinib—CYP2D6—cerebellum—meningioma	0.00108	0.00476	CbGeAlD
Gefitinib—ABCB1—spinal cord—meningioma	0.000977	0.00432	CbGeAlD
Gefitinib—CYP2D6—brain—meningioma	0.000875	0.00387	CbGeAlD
Gefitinib—ABCB1—cerebellum—meningioma	0.000775	0.00342	CbGeAlD
Gefitinib—MKNK1—Disease—PDGFB—meningioma	0.000634	0.000917	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—ERBB2—meningioma	0.000634	0.000917	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by ERBB2—AKT1—meningioma	0.000633	0.000915	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000632	0.000913	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 signaling—AKT1—meningioma	0.00063	0.000911	CbGpPWpGaD
Gefitinib—ABCB1—brain—meningioma	0.000629	0.00278	CbGeAlD
Gefitinib—EGFR—B Cell Activation—ERBB2—meningioma	0.000621	0.000898	CbGpPWpGaD
Gefitinib—ERBB3—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000621	0.000898	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—PTEN—meningioma	0.000618	0.000893	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—SMO—meningioma	0.000616	0.000891	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—PTEN—meningioma	0.000615	0.000889	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—PTEN—meningioma	0.000615	0.000889	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—PTEN—meningioma	0.000611	0.000884	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways in Glioblastoma—AKT1—meningioma	0.000611	0.000883	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—PTEN—meningioma	0.000609	0.00088	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—PTEN—meningioma	0.0006	0.000867	CbGpPWpGaD
Gefitinib—IRAK1—Regulation of toll-like receptor signaling pathway—AKT1—meningioma	0.000599	0.000866	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—ERBB2—meningioma	0.000595	0.00086	CbGpPWpGaD
Gefitinib—ERBB3—DAP12 interactions—AKT1—meningioma	0.000593	0.000857	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by FGFR in disease—AKT1—meningioma	0.000593	0.000857	CbGpPWpGaD
Gefitinib—ERBB3—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.000593	0.000857	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by WNT in cancer—AKT1—meningioma	0.000592	0.000856	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PGR—meningioma	0.000591	0.000854	CbGpPWpGaD
Gefitinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—meningioma	0.000588	0.00085	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—ERBB2—meningioma	0.000588	0.00085	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR—AKT1—meningioma	0.000587	0.000849	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—PTEN—meningioma	0.000583	0.000843	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by EGFR in Cancer—AKT1—meningioma	0.000582	0.000842	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—PDGFB—meningioma	0.000582	0.000842	CbGpPWpGaD
Gefitinib—MAP2K5—Focal Adhesion—AKT1—meningioma	0.000581	0.00084	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by PDGF—AKT1—meningioma	0.00058	0.000838	CbGpPWpGaD
Gefitinib—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—meningioma	0.000579	0.000837	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—HES1—meningioma	0.000577	0.000834	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TSHB—meningioma	0.000573	0.000828	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—PTEN—meningioma	0.000572	0.000828	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—PTEN—meningioma	0.000572	0.000828	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—PTEN—meningioma	0.000572	0.000828	CbGpPWpGaD
Gefitinib—EGFR—Androgen receptor signaling pathway—AKT1—meningioma	0.000572	0.000827	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—PTEN—meningioma	0.000567	0.00082	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—PTEN—meningioma	0.000562	0.000813	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—PTEN—meningioma	0.00056	0.00081	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TSHB—meningioma	0.000552	0.000799	CbGpPWpGaD
Gefitinib—ERBB3—B Cell Activation—AKT1—meningioma	0.000548	0.000793	CbGpPWpGaD
Gefitinib—MAP2K5—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000545	0.000787	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—PTEN—meningioma	0.000541	0.000782	CbGpPWpGaD
Gefitinib—EGFR—Spinal Cord Injury—TP53—meningioma	0.00054	0.000781	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000539	0.000779	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—ALAD—meningioma	0.000533	0.00077	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—PTEN—meningioma	0.00053	0.000766	CbGpPWpGaD
Gefitinib—EGFR—PI-3K cascade—AKT1—meningioma	0.000529	0.000766	CbGpPWpGaD
Gefitinib—ERBB3—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000525	0.000759	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—TSHB—meningioma	0.00052	0.000753	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—HES1—meningioma	0.000519	0.000751	CbGpPWpGaD
Gefitinib—EGFR—PI3K/AKT activation—AKT1—meningioma	0.000517	0.000747	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—HES1—meningioma	0.000515	0.000745	CbGpPWpGaD
Gefitinib—EGFR—GAB1 signalosome—AKT1—meningioma	0.000513	0.000741	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CD34—meningioma	0.000512	0.00074	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—PDGFB—meningioma	0.000511	0.000738	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—PTEN—meningioma	0.000507	0.000733	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—PTEN—meningioma	0.000501	0.000725	CbGpPWpGaD
Gefitinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—meningioma	0.000501	0.000724	CbGpPWpGaD
Gefitinib—EGFR—ErbB1 downstream signaling—AKT1—meningioma	0.000501	0.000724	CbGpPWpGaD
Gefitinib—ALB—Folate Metabolism—TP53—meningioma	0.000496	0.000716	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PDGFB—meningioma	0.000493	0.000713	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling by Wnt—AKT1—meningioma	0.000488	0.000706	CbGpPWpGaD
Gefitinib—EGFR—Immune System—CTSL—meningioma	0.000488	0.000706	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—SMO—meningioma	0.000487	0.000704	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—PDGFB—meningioma	0.000483	0.000699	CbGpPWpGaD
Gefitinib—EGFR—Direct p53 effectors—TP53—meningioma	0.000471	0.000682	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—SMO—meningioma	0.00047	0.000679	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—ERBB2—meningioma	0.000469	0.000677	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PGR—meningioma	0.000467	0.000675	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TSHB—meningioma	0.00046	0.000665	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—ERBB2—meningioma	0.000457	0.000661	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PGR—meningioma	0.00045	0.000651	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—ERBB2—meningioma	0.00045	0.000651	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PDGFB—meningioma	0.000444	0.000642	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—TP53—meningioma	0.000444	0.000641	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—SMO—meningioma	0.000443	0.00064	CbGpPWpGaD
Gefitinib—ERBB3—Disease—HES1—meningioma	0.00044	0.000636	CbGpPWpGaD
Gefitinib—CHEK2—Cell Cycle—TP53—meningioma	0.000438	0.000633	CbGpPWpGaD
Gefitinib—MKNK1—Disease—ERBB2—meningioma	0.000425	0.000615	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling by NGF—AKT1—meningioma	0.000419	0.000606	CbGpPWpGaD
Gefitinib—EGFR—Disease—CST3—meningioma	0.000416	0.000601	CbGpPWpGaD
Gefitinib—EGFR—Axon guidance—ERBB2—meningioma	0.000414	0.000598	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—TP53—meningioma	0.000407	0.000589	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—PDGFB—meningioma	0.000407	0.000589	CbGpPWpGaD
Gefitinib—EPHA6—Developmental Biology—AKT1—meningioma	0.000406	0.000587	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—HES1—meningioma	0.000404	0.000584	CbGpPWpGaD
Gefitinib—ERBB3—Signaling by NGF—AKT1—meningioma	0.000404	0.000584	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—PTEN—meningioma	0.0004	0.000578	CbGpPWpGaD
Gefitinib—EGFR—Signaling by SCF-KIT—AKT1—meningioma	0.000396	0.000572	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—SMO—meningioma	0.000391	0.000565	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—ERBB2—meningioma	0.00039	0.000564	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—PTEN—meningioma	0.00039	0.000564	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—PDGFB—meningioma	0.000389	0.000563	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—PTEN—meningioma	0.000384	0.000555	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—ALAD—meningioma	0.000382	0.000552	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling of activated FGFR—AKT1—meningioma	0.000379	0.000548	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PDGFB—meningioma	0.000376	0.000544	CbGpPWpGaD
Gefitinib—CSNK1E—Cell Cycle—TP53—meningioma	0.000375	0.000542	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PGR—meningioma	0.000375	0.000542	CbGpPWpGaD
Gefitinib—EGFR—Integrated Breast Cancer Pathway—AKT1—meningioma	0.000375	0.000542	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—PDGFB—meningioma	0.000374	0.00054	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB4—AKT1—meningioma	0.000373	0.000539	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000368	0.000532	CbGpPWpGaD
Gefitinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—meningioma	0.000367	0.00053	CbGpPWpGaD
Gefitinib—MKNK1—Disease—PTEN—meningioma	0.000363	0.000524	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—ALAD—meningioma	0.000361	0.000521	CbGpPWpGaD
Gefitinib—EGFR—Downstream signal transduction—AKT1—meningioma	0.000356	0.000515	CbGpPWpGaD
Gefitinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—meningioma	0.000354	0.000512	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR—AKT1—meningioma	0.000354	0.000512	CbGpPWpGaD
Gefitinib—EGFR—Signaling by ERBB2—AKT1—meningioma	0.000352	0.00051	CbGpPWpGaD
Gefitinib—EGFR—DAP12 signaling—AKT1—meningioma	0.000351	0.000507	CbGpPWpGaD
Gefitinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—meningioma	0.000346	0.0005	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PDGFB—meningioma	0.000345	0.0005	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PLAUR—meningioma	0.000344	0.000498	CbGpPWpGaD
Gefitinib—EGFR—MAPK Signaling Pathway—AKT1—meningioma	0.000344	0.000497	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—TSHB—meningioma	0.000343	0.000496	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—ERBB2—meningioma	0.000342	0.000495	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—PDGFB—meningioma	0.000339	0.00049	CbGpPWpGaD
Gefitinib—IRAK1—Signaling by NGF—AKT1—meningioma	0.000336	0.000486	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—PTEN—meningioma	0.000333	0.000481	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—ERBB2—meningioma	0.000331	0.000478	CbGpPWpGaD
Gefitinib—EGFR—Signaling by FGFR in disease—AKT1—meningioma	0.00033	0.000477	CbGpPWpGaD
Gefitinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—meningioma	0.00033	0.000477	CbGpPWpGaD
Gefitinib—EGFR—DAP12 interactions—AKT1—meningioma	0.00033	0.000477	CbGpPWpGaD
Gefitinib—ALB—Metabolism—ALAD—meningioma	0.000329	0.000475	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR—AKT1—meningioma	0.000327	0.000473	CbGpPWpGaD
Gefitinib—EGFR—Signaling by EGFR in Cancer—AKT1—meningioma	0.000324	0.000469	CbGpPWpGaD
Gefitinib—EGFR—Signaling by PDGF—AKT1—meningioma	0.000323	0.000467	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—HES1—meningioma	0.000319	0.000462	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—meningioma	0.000319	0.000461	CbGpPWpGaD
Gefitinib—EGFR—Focal Adhesion—AKT1—meningioma	0.000312	0.000451	CbGpPWpGaD
Gefitinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.00031	0.000449	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—HES1—meningioma	0.000308	0.000445	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TSHB—meningioma	0.000307	0.000445	CbGpPWpGaD
Gefitinib—EGFR—B Cell Activation—AKT1—meningioma	0.000305	0.000441	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—ERBB2—meningioma	0.000298	0.000431	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—ERBB2—meningioma	0.000295	0.000427	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—ALAD—meningioma	0.000295	0.000427	CbGpPWpGaD
Gefitinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—meningioma	0.000292	0.000423	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—PTEN—meningioma	0.000292	0.000422	CbGpPWpGaD
Gefitinib—IRAK4—Innate Immune System—AKT1—meningioma	0.000289	0.000418	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—ALAD—meningioma	0.000288	0.000416	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—PTEN—meningioma	0.000282	0.000408	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PDGFB—meningioma	0.000273	0.000395	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—ERBB2—meningioma	0.000273	0.000395	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—meningioma	0.000272	0.000393	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—ALAD—meningioma	0.000271	0.000392	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—ALAD—meningioma	0.000269	0.000389	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PDGFB—meningioma	0.000263	0.000381	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—SMO—meningioma	0.000261	0.000378	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—ERBB2—meningioma	0.000261	0.000377	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—HES1—meningioma	0.000256	0.000371	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—PTEN—meningioma	0.000254	0.000367	CbGpPWpGaD
Gefitinib—ERBB3—Disease—ERBB2—meningioma	0.000252	0.000364	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PGR—meningioma	0.000251	0.000362	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—ERBB2—meningioma	0.00025	0.000362	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PDGFB—meningioma	0.000249	0.00036	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—TSHB—meningioma	0.000246	0.000356	CbGpPWpGaD
Gefitinib—EGFR—Disease—HES1—meningioma	0.000245	0.000354	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—PLAU—meningioma	0.000242	0.000349	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—PTEN—meningioma	0.000233	0.000336	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—TSHB—meningioma	0.000232	0.000336	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—ERBB2—meningioma	0.000232	0.000335	CbGpPWpGaD
Gefitinib—ERBB3—Innate Immune System—AKT1—meningioma	0.00023	0.000333	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—ERBB2—meningioma	0.000227	0.000329	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PDGFB—meningioma	0.000227	0.000328	CbGpPWpGaD
Gefitinib—EGFR—Signaling by NGF—AKT1—meningioma	0.000225	0.000325	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—PTEN—meningioma	0.000222	0.000322	CbGpPWpGaD
Gefitinib—ERBB3—Adaptive Immune System—AKT1—meningioma	0.000221	0.00032	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PDGFB—meningioma	0.000219	0.000317	CbGpPWpGaD
Gefitinib—ERBB3—Disease—PTEN—meningioma	0.000215	0.000311	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—PTEN—meningioma	0.000214	0.000309	CbGpPWpGaD
Gefitinib—ALB—Metabolism—TSHB—meningioma	0.000212	0.000306	CbGpPWpGaD
Gefitinib—EGFR—Disease—PDGFB—meningioma	0.000209	0.000303	CbGpPWpGaD
Gefitinib—MKNK1—Disease—AKT1—meningioma	0.000209	0.000302	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—PTEN—meningioma	0.000197	0.000286	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—PTEN—meningioma	0.000194	0.00028	CbGpPWpGaD
Gefitinib—IRAK1—Innate Immune System—AKT1—meningioma	0.000192	0.000277	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—TSHB—meningioma	0.00019	0.000275	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—TSHB—meningioma	0.000186	0.000268	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—meningioma	0.000186	0.000268	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—ERBB2—meningioma	0.000183	0.000265	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—ALAD—meningioma	0.000177	0.000257	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—ERBB2—meningioma	0.000176	0.000255	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—TSHB—meningioma	0.000175	0.000253	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—TSHB—meningioma	0.000173	0.000251	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—TP53—meningioma	0.000173	0.000251	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—HES1—meningioma	0.000171	0.000248	CbGpPWpGaD
Gefitinib—IRAK4—Immune System—AKT1—meningioma	0.000168	0.000243	CbGpPWpGaD
Gefitinib—CSNK1E—Disease—AKT1—meningioma	0.000163	0.000235	CbGpPWpGaD
Gefitinib—ALB—Platelet activation, signaling and aggregation—AKT1—meningioma	0.000159	0.00023	CbGpPWpGaD
Gefitinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—meningioma	0.000157	0.000227	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—PTEN—meningioma	0.000156	0.000226	CbGpPWpGaD
Gefitinib—EGFR—Immune System—ERBB2—meningioma	0.000152	0.00022	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—PTEN—meningioma	0.00015	0.000218	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—ERBB2—meningioma	0.000147	0.000212	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PDGFB—meningioma	0.000147	0.000212	CbGpPWpGaD
Gefitinib—MKNK1—Signaling Pathways—AKT1—meningioma	0.000146	0.000212	CbGpPWpGaD
Gefitinib—EGFR—Developmental Biology—AKT1—meningioma	0.000145	0.00021	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000142	0.000206	CbGpPWpGaD
Gefitinib—EGFR—Disease—ERBB2—meningioma	0.00014	0.000203	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—TP53—meningioma	0.000135	0.000195	CbGpPWpGaD
Gefitinib—ERBB3—Immune System—AKT1—meningioma	0.000134	0.000194	CbGpPWpGaD
Gefitinib—ALB—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.00013	0.000187	CbGpPWpGaD
Gefitinib—EGFR—Immune System—PTEN—meningioma	0.00013	0.000187	CbGpPWpGaD
Gefitinib—EGFR—Innate Immune System—AKT1—meningioma	0.000128	0.000185	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—PTEN—meningioma	0.000125	0.000181	CbGpPWpGaD
Gefitinib—ERBB3—Disease—AKT1—meningioma	0.000124	0.000179	CbGpPWpGaD
Gefitinib—EGFR—Adaptive Immune System—AKT1—meningioma	0.000123	0.000178	CbGpPWpGaD
Gefitinib—EGFR—Disease—PTEN—meningioma	0.00012	0.000173	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000116	0.000168	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—TSHB—meningioma	0.000114	0.000165	CbGpPWpGaD
Gefitinib—CSNK1E—Signaling Pathways—AKT1—meningioma	0.000114	0.000165	CbGpPWpGaD
Gefitinib—IRAK1—Immune System—AKT1—meningioma	0.000112	0.000161	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—TP53—meningioma	0.000107	0.000154	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—meningioma	0.000106	0.000153	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—TP53—meningioma	0.000103	0.000148	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—ERBB2—meningioma	9.82e-05	0.000142	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—TP53—meningioma	9.71e-05	0.00014	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—PTEN—meningioma	9.35e-05	0.000135	CbGpPWpGaD
Gefitinib—MAP2K5—Signaling Pathways—AKT1—meningioma	9e-05	0.00013	CbGpPWpGaD
Gefitinib—ERBB3—Signaling Pathways—AKT1—meningioma	8.67e-05	0.000125	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—TP53—meningioma	8.55e-05	0.000124	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—PTEN—meningioma	8.38e-05	0.000121	CbGpPWpGaD
Gefitinib—ALB—Hemostasis—AKT1—meningioma	8.2e-05	0.000119	CbGpPWpGaD
Gefitinib—EGFR—Signaling by GPCR—AKT1—meningioma	8.17e-05	0.000118	CbGpPWpGaD
Gefitinib—EGFR—Immune System—AKT1—meningioma	7.47e-05	0.000108	CbGpPWpGaD
Gefitinib—IRAK1—Signaling Pathways—AKT1—meningioma	7.22e-05	0.000104	CbGpPWpGaD
Gefitinib—EGFR—Disease—AKT1—meningioma	6.89e-05	9.97e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—PTEN—meningioma	6.7e-05	9.69e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—PTEN—meningioma	6.33e-05	9.15e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—PTEN—meningioma	5.77e-05	8.34e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—TP53—meningioma	5.72e-05	8.27e-05	CbGpPWpGaD
Gefitinib—ABCG2—Metabolism—AKT1—meningioma	5.39e-05	7.79e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—PTEN—meningioma	5.18e-05	7.49e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—PTEN—meningioma	5.06e-05	7.31e-05	CbGpPWpGaD
Gefitinib—EGFR—Signaling Pathways—AKT1—meningioma	4.83e-05	6.98e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—PTEN—meningioma	4.76e-05	6.89e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—PTEN—meningioma	4.72e-05	6.83e-05	CbGpPWpGaD
Gefitinib—CYP3A5—Metabolism—AKT1—meningioma	3.86e-05	5.58e-05	CbGpPWpGaD
Gefitinib—CYP1A1—Metabolism—AKT1—meningioma	3.65e-05	5.28e-05	CbGpPWpGaD
Gefitinib—ALB—Metabolism—AKT1—meningioma	3.33e-05	4.81e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—PTEN—meningioma	3.12e-05	4.5e-05	CbGpPWpGaD
Gefitinib—CYP2C19—Metabolism—AKT1—meningioma	2.99e-05	4.32e-05	CbGpPWpGaD
Gefitinib—ABCB1—Metabolism—AKT1—meningioma	2.91e-05	4.21e-05	CbGpPWpGaD
Gefitinib—CYP2D6—Metabolism—AKT1—meningioma	2.75e-05	3.97e-05	CbGpPWpGaD
Gefitinib—CYP2C9—Metabolism—AKT1—meningioma	2.72e-05	3.94e-05	CbGpPWpGaD
Gefitinib—CYP3A4—Metabolism—AKT1—meningioma	1.8e-05	2.6e-05	CbGpPWpGaD
